Definition of sample plasmas
Plasma . | Source . | Age, y . | Sex . | % FV . | % FVIII . | % protein S . |
|---|---|---|---|---|---|---|
| Normal pool | Healthy blood donors (n = 74) | 40.0 (± 8.9 SD) | M/F (45/29) | 100 | 100 | 100 |
| FVR2 homozygote | Healthy blood donor | 55 | M | 77 | 150 | 132 |
| FVR2 homozygote | Coronaropathic patient | 49 | M | 80 | 82 | 104 |
| FVLeiden homozygote | Healthy blood donor | 28 | F | 91 | 76 | 74 |
| FVLeiden homozygote | Thrombotic patient | 75 | M | 121 | 155 | 116 |
| FV-deficient plasma | Commercial (George King) | — | — | < 1 | 118 | 113 |
Plasma . | Source . | Age, y . | Sex . | % FV . | % FVIII . | % protein S . |
|---|---|---|---|---|---|---|
| Normal pool | Healthy blood donors (n = 74) | 40.0 (± 8.9 SD) | M/F (45/29) | 100 | 100 | 100 |
| FVR2 homozygote | Healthy blood donor | 55 | M | 77 | 150 | 132 |
| FVR2 homozygote | Coronaropathic patient | 49 | M | 80 | 82 | 104 |
| FVLeiden homozygote | Healthy blood donor | 28 | F | 91 | 76 | 74 |
| FVLeiden homozygote | Thrombotic patient | 75 | M | 121 | 155 | 116 |
| FV-deficient plasma | Commercial (George King) | — | — | < 1 | 118 | 113 |
— indicates information not provided by the firm.